دورية أكاديمية

1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK

التفاصيل البيبلوغرافية
العنوان: 1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
المؤلفون: Kopp, C., Lorenzen, S., Gaiser, T., Thuss-Patience, P.C., Schenk, M., Lindig, U., Kretzschmar, A., Heuer, V., Goekkurt, E., Haag, G.M., Riera Knorrenschild, J., Bolling, C., Hofheinz, R.D., Siebenhuener, A.R., Irahara, N., Waberer, L., Pauligk, C., Götze, T.O., Homann, N., Al-Batran, S-E.
المصدر: In Annals of Oncology September 2021 32 Supplement 5:S1069-S1070
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2021.08.1539